Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Allison Transmission
ALSN
$8.83B
| $227M | 0.2% |
6,167,919
+774,500
| +14% | +$27.7M |
2013 Q3
27 quarters
|
|
102
Duke Energy
DUK
$89.7B
| $222M | 0.19% |
2,781,964
-4,296,468
| -61% | -$363M |
2014 Q1
25 quarters
|
|
103
Seagate
STX
$179B
| $221M | 0.19% |
4,574,629
-1,352,501
| -23% | -$67.9M |
2018 Q2
8 quarters
|
|
104
Ryanair
RYAAY
$28.1B
| $214M | 0.18% |
8,070,520
-184,750
| -2% | -$4.68M |
2013 Q2
28 quarters
|
|
105
Snap
SNAP
$9.79B
| $209M | 0.18% |
8,902,400
+5,971,100
| +204% | +$106M |
2019 Q1
5 quarters
|
|
106
Peloton Interactive
PTON
$2.12B
| $209M | 0.18% |
3,618,800
+3,412,261
| +1,652% | +$141M |
2020 Q1
1 quarter
|
|
107
JPMorgan Chase
JPM
$868B
| $207M | 0.18% |
2,204,786
+538,600
| +32% | +$51.1M |
2020 Q1
1 quarter
|
|
108
Ericsson
ERIC
$30.6B
| $207M | 0.18% |
22,281,829
-6,977,971
| -24% | -$60.6M |
2018 Q2
8 quarters
|
|
109
Fortis
FTS
$27B
| $206M | 0.18% |
5,408,097
+580,292
| +12% | +$22.1M |
2016 Q4
14 quarters
|
|
110
Datadog
DDOG
$99.8B
| $204M | 0.18% |
2,349,100
+1,801,400
| +329% | +$110M |
2020 Q1
1 quarter
|
|
111
Progressive
PGR
$126B
| $204M | 0.18% |
2,542,582
-1,819,286
| -42% | -$142M |
2015 Q4
18 quarters
|
|
|
KL
112
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $203M | 0.18% |
4,923,334
+322,540
| +7% | +$12.5M |
2017 Q3
11 quarters
|
|
|
ADSW
113
DELISTED
Advanced Disposal Services Inc
ADSW
| $200M | 0.17% |
6,627,818
+1,574,058
| +31% | +$50.2M |
2017 Q1
13 quarters
|
|
114
American Electric Power
AEP
$66.2B
| $199M | 0.17% |
2,493,622
-3,036,518
| -55% | -$248M |
2014 Q3
23 quarters
|
|
115
Medtronic
MDT
$112B
| $197M | 0.17% |
2,144,141
+1,959,245
| +1,060% | +$188M |
2019 Q2
4 quarters
|
|
116
Gen Digital
GEN
$13.5B
| $196M | 0.17% |
9,907,138
+7,864,600
| +385% | +$160M |
2020 Q1
1 quarter
|
|
117
Haemonetics
HAE
$5.36B
| $196M | 0.17% |
2,187,785
+3,400
| +0.2% | +$343K |
2013 Q2
28 quarters
|
|
118
Bilibili
BILI
$6.03B
| $194M | 0.17% |
4,187,150
+92,600
| +2% | +$3.01M |
2019 Q1
5 quarters
|
|
119
BP
BP
$120B
| $194M | 0.17% |
8,304,093
-5,600,300
| -40% | -$134M |
2017 Q2
12 quarters
|
|
120
Take-Two Interactive
TTWO
$39.3B
| $189M | 0.16% |
1,354,440
+956,290
| +240% | +$125M |
2019 Q4
2 quarters
|
|
121
Uber
UBER
$140B
| $187M | 0.16% |
+6,030,316
| New | +$188M |
2020 Q2
0 quarters
|
|
122
lululemon athletica
LULU
$10.2B
| $186M | 0.16% |
595,814
-300,500
| -34% | -$76.8M |
2019 Q1
5 quarters
|
|
123
Gold Fields
GFI
$31.6B
| $186M | 0.16% |
19,752,400
-725,000
| -4% | -$5.49M |
2013 Q2
28 quarters
|
|
|
K
124
DELISTED
Kellanova
K
| $185M | 0.16% |
2,984,627
-673,080
| -18% | -$40.7M |
2018 Q3
7 quarters
|
|
|
ATVI
125
DELISTED
Activision Blizzard
ATVI
| $181M | 0.16% |
2,388,898
+1,624,000
| +212% | +$113M |
2020 Q1
1 quarter
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.